Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade.
Klepsch V, Hermann-Kleiter N, Do-Dinh P, Jakic B, Offermann A, Efremova M, Sopper S, Rieder D, Krogsdam A, Gamerith G, Perner S, Tzankov A, Trajanoski Z, Wolf D, Baier G.
Klepsch V, et al. Among authors: tzankov a.
Nat Commun. 2018 Apr 18;9(1):1538. doi: 10.1038/s41467-018-04004-2.
Nat Commun. 2018.
PMID: 29670099
Free PMC article.